On March 4, 2026, LB Pharmaceuticals Inc promoted Gad Soffer to Chief Operating and Business Officer with a salary of $505,000, and appointed Robert A. Lenz to the Board, effective immediately, with compensation details outlined. This filing includes a press release dated March 9, 2026, regarding Dr. Lenz's appointment.